Transcriptional Consequences of Topoisomerase InhibitionIrene Collins, David Levens|Molecular and Cellular Biology|2001Cited by 117
Drugging the “Undruggable” MYCN Oncogenic Transcription Factor: Overcoming Previous Obstacles to Impact Childhood CancersAdam J. Wolpaw, Yaël P. Mossé, Gabriele Büchel et al.|Cancer Research|2021Cited by 70
Excessive MYC-topoisome activity triggers acute DNA damage, MYC degradation, and replacement by a p53-topoisomeSubhendu Das, David Levens|Molecular Cell|2024Cited by 16